DNA Binding Domain-independent Pathways Are Involved in EWS/FLI1-mediated Oncogenesis
Open Access
- 1 November 2001
- journal article
- Published by Elsevier
- Vol. 276 (45) , 41977-41984
- https://doi.org/10.1074/jbc.m106757200
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- EWS·Fli-1 Fusion Protein Interacts with Hyperphosphorylated RNA Polymerase II and Interferes with Serine-Arginine Protein-mediated RNA SplicingJournal of Biological Chemistry, 2000
- The Splicing Factor U1C Represses EWS/FLI-mediated TransactivationJournal of Biological Chemistry, 2000
- TLS-ERG Leukemia Fusion Protein Inhibits RNA Splicing Mediated by Serine-Arginine ProteinsMolecular and Cellular Biology, 2000
- Molecular genetics of chromosome translocations involvingEWSand related family membersPhysiological Genomics, 1999
- Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cellsOncogene, 1999
- Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activityOncogene, 1999
- Oncoprotein TLS Interacts with Serine-Arginine Proteins Involved in RNA SplicingPublished by Elsevier ,1998
- Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase IIOncogene, 1998
- hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II.The EMBO Journal, 1996
- Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.Proceedings of the National Academy of Sciences, 1993